BioCatalystWatch
XBIOWorkspace / XBIO / OverviewCompany library
Xenetic Biosciences, Inc. logo

Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc. (XBIO)

Website

Price
Market cap
Next catalystDec 12, 2026dnase-i · Conference presentationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

XBIO-015

NETs

PreINDP1P2P3FilingApproved
Upcoming / outlook

XBIO-015

XBIO-015

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

XBIO-015

NETs

PreINDP1P2P3FilingApproved
Upcoming / outlook

XBIO-015

XBIO-015

PreINDP1P2P3FilingApproved

Other pipelines

Partner / License out

PreINDP1P2P3FilingApproved

History / paused

PreINDP1P2P3FilingApproved

Tumor-specific B-cell receptor × Tumor-specific neoantigens

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

XBIO PR & News

PR & News

XBIO SEC archive